NH Korindo Sekuritas Indonesia
Menu
  • OUR SERVICE
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
    • Equity
    • Fixed Income
    • Margin
    • Bonds
    • Investment Banking
      • IPO
      • E-IPO
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • ABOUT US
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • CONTACT
  • Register
  • EN
    • ID
  • ID
  • EN

Kalbe Farma Tbk (KLBF) Flat Growth Ahead

  • Author
  • Recent Posts
NHKSI Research Team
NHKSI Research Team
NHKSI Research Team
Latest posts by NHKSI Research Team (see all)
  • Daily Report | 8 Apr 2026 - April 8, 2026
  • XA Update Report | PT Tower Bersama Infrastructure Tbk. (TBIG) – TBIG FY25: Flattish Performance with a Steady but Uninspiring Growth Trajectory - April 7, 2026
  • Fixed Income News | Obligasi Batu Bara Asia Makin Menguntungkan di Tengah Perang Iran - April 7, 2026

Growth of 2.4% in Sales
KLBF’s sales grew by 2.4% from IDR4.89 trillion in 1Q17 into IDR5.01 trillion in 1Q18. The growth was boosted by the sales growth of 3.6%, 2.1%, 2.8%, and 0.5% respectively posted by the prescription drugs, the nutritional food, the distribution, and the consumer health.

Lowest Sales Growth by the Nutritional Food
Based on the Nielsen Retail data, the sales volume of dairy powder in Indonesia edged down 2.5% from 203 million tons in 2016 into 198 million tons in 2017. We estimate that the downtrend likely impacted on the nutritional food. Of note, the nutritional food posted the 1Q18 growth of 2.1% the last-5-year-lowest growth.

Download full report HERE.

Share This Article

Related Article


XA Update Report | PT Tower Bersama Infrastructure Tbk. (TBIG) – TBIG FY25: Flattish Performance with a Steady but Uninspiring Growth Trajectory

07 Apr 2026

In the FY25 period, TBIG recorded revenue of IDR 6.91 trillion, a slight increase of +0.6% YoY (FY24: IDR 6.87 trillion). On a quarterly basis, 4Q25 revenue was relatively flat at +2% QoQ and 0.4% YoY, reaching IDR 1.75 trillion (3Q25: IDR 1.71 trillion | 4Q24: IDR 1.74 trillion).

XA Research Short Notes | PT Fore Kopi Indonesia Tbk. (FORE) – Strong FY25 Earnings Driven by Strategic Expansion and Disciplined IPO Fund Utilization

01 Apr 2026

FORE reported a strong FY25 performance with net profit rising to IDR 90.1 billion (+55% YoY).

XA Market Update Report | Fundamentals Say Go, Conditions Say No

31 Mar 2026

We project JCI to begin rebounding back in the 2H26 to the range of 9,500-9,700. We have downgraded our JCI base case from 10,000.

More Article

Daily Report

08 Apr 2026

Daily Report | 8 Apr 2026

Wall Street indexes closed mostly flat on Tuesday, but managed to rebound from intraday...

READ MORE

Analysis Report

07 Apr 2026

XA Update Report | PT Tower Bersama Infrastruct...

In the FY25 period, TBIG recorded revenue of IDR 6.91 trillion, a slight increase of +0...

READ MORE

Uncategorized

07 Apr 2026

Fixed Income News | Obligasi Batu Bara Asia Mak...

Krisis energi global yang belum pernah terjadi sebelumnya telah mendorong Asia kembali ...

READ MORE


Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia berizin dan diawasi oleh Otoritas Jasa Keuangan (OJK).


© Copyright 2026 NH Korindo Sekuritas. All rights reserved.